117 related articles for article (PubMed ID: 24172857)
21. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
22. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
24. [The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression].
Wang G; Du C; Lin Q
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):340-3. PubMed ID: 10374442
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of primary and metastatic tumours in synchronous multifocal colonic and bronchopulmonary adenocarcinoma by targeted next-generation sequencing.
Kunze K; Frank M; Bodner J; Reichert M; Blau W; Sibelius U; Rummel M; Hörbelt R; Padberg W; Engenhart-Cabillic R; Bräuninger A; Gattenlöhner S
Histopathology; 2014 Jun; 64(7):1041-3. PubMed ID: 24372290
[No Abstract] [Full Text] [Related]
26. Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium.
Tops BB; Normanno N; Kurth H; Amato E; Mafficini A; Rieber N; Le Corre D; Rachiglio AM; Reiman A; Sheils O; Noppen C; Lacroix L; Cree IA; Scarpa A; Ligtenberg MJ; Laurent-Puig P
BMC Cancer; 2015 Jan; 15():26. PubMed ID: 25637035
[TBL] [Abstract][Full Text] [Related]
27. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
[TBL] [Abstract][Full Text] [Related]
28. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
29. Exome sequencing of contralateral breast cancer identifies metastatic disease.
Klevebring D; Lindberg J; Rockberg J; Hilliges C; Hall P; Sandberg M; Czene K
Breast Cancer Res Treat; 2015 Jun; 151(2):319-24. PubMed ID: 25922084
[TBL] [Abstract][Full Text] [Related]
30. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.
Leong TL; Gayevskiy V; Steinfort DP; De Massy MR; Gonzalez-Rajal A; Marini KD; Stone E; Chin V; Havryk A; Plit M; Irving LB; Jennings BR; McCloy RA; Jayasekara WSN; Alamgeer M; Boolell V; Field A; Russell PA; Kumar B; Gough DJ; Szczepny A; Ganju V; Rossello FJ; Cain JE; Papenfuss AT; Asselin-Labat ML; Cowley MJ; Watkins DN
Oncogene; 2019 Mar; 38(10):1661-1675. PubMed ID: 30348992
[TBL] [Abstract][Full Text] [Related]
31. Immune response-associated gene analysis of 1,000 cancer patients using whole-exome sequencing and gene expression profiling-Project HOPE.
Akiyama Y; Kondou R; Iizuka A; Ohshima K; Urakami K; Nagashima T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Kusuhara M; Mochizuki T; Yamaguchi K
Biomed Res; 2016; 37(4):233-42. PubMed ID: 27544999
[TBL] [Abstract][Full Text] [Related]
32. Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing.
Franceschi S; Lessi F; Aretini P; Mazzanti CM; Menicagli M; La Ferla M; De Gregorio V; Caramella D; Naccarato AG; Bevilacqua G; Bonadio AG; Pasqualetti F
Neuro Oncol; 2016 Feb; 18(2):298-300. PubMed ID: 26803811
[No Abstract] [Full Text] [Related]
33. Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing.
Yu C; Yu J; Yao X; Wu WK; Lu Y; Tang S; Li X; Bao L; Li X; Hou Y; Wu R; Jian M; Chen R; Zhang F; Xu L; Fan F; He J; Liang Q; Wang H; Hu X; He M; Zhang X; Zheng H; Li Q; Wu H; Chen Y; Yang X; Zhu S; Xu X; Yang H; Wang J; Zhang X; Sung JJ; Li Y; Wang J
Cell Res; 2014 Jun; 24(6):701-12. PubMed ID: 24699064
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary study of exon sequence in pneumoconiosis and pneumoconiosis complicated with lung cancer using high-throughput sequencing technology].
Jiang MF; Li L; Wang Z; Zhang CL; Zhang H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Nov; 35(11):801-806. PubMed ID: 29316748
[No Abstract] [Full Text] [Related]
35. A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
Tricoli JV; Boardman LA; Patidar R; Sindiri S; Jang JS; Walsh WD; McGregor PM; Camalier CE; Mehaffey MG; Furman WL; Bahrami A; Williams PM; Lih CJ; Conley BA; Khan J
Cancer; 2018 Mar; 124(5):1070-1082. PubMed ID: 29194591
[TBL] [Abstract][Full Text] [Related]
36. Latency and interval therapy affect the evolution in metastatic colorectal cancer.
Nikbakht H; Jessa S; Sukhai MA; Arseneault M; Zhang T; Letourneau L; Thomas M; Bourgey M; Roehrl MHA; Eveleigh R; Chen EX; Krzyzanowska M; Moore MJ; Giesler A; Yu C; Bedard PL; Kamel-Reid S; Majewski J; Siu LL; Riazalhosseini Y; Graham DM
Sci Rep; 2020 Jan; 10(1):581. PubMed ID: 31953485
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.
Zhou Y; Rideout WM; Bressel A; Yalavarthi S; Zi T; Potz D; Farlow S; Brodeur J; Monti A; Reddipalli S; Xiao Q; Bottega S; Feng B; Chiu MI; Bosenberg M; Heyer J
PLoS One; 2014; 9(8):e105886. PubMed ID: 25162504
[TBL] [Abstract][Full Text] [Related]
38. DDR Pathway Alteration, Tumor Mutation Burden, and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole Exome and Targeted Gene Sequencing.
Luo P; Lin A; Li K; Wei T; Zhang J
J Thorac Oncol; 2019 Dec; 14(12):e276-e279. PubMed ID: 31757380
[No Abstract] [Full Text] [Related]
39. In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing.
Park S; Lee SH; Park K
J Thorac Oncol; 2019 Dec; 14(12):e279-e280. PubMed ID: 31757381
[No Abstract] [Full Text] [Related]
40. Identification of certain cancer-mediating genes using Gaussian fuzzy cluster validity index.
Ghosh A; De RK
J Biosci; 2015 Oct; 40(4):741-54. PubMed ID: 26564976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
